Issuance of Stock Acquisition Rights
First written in FY2018-Q2. 7 of 10 entries say "Advanced", first in FY2018. Latest entry: FY2023.
The whole theme swung hardest in 2026: 1 of 9 companies on the "Worse" side.
3 other companies' latest entry also says "Advanced".
- FY2023AdvancedAnnual report
「Series 13 Stock Acquisition Rights: Increase during the fiscal year: 3,700,000; Decrease during the fiscal year: 2,550,000; At the end of the fiscal year: 1,150,000」
The company issued Series 13 Stock Acquisition Rights equivalent to 3.7 million shares, of which rights equivalent to 2.55 million shares were exercised. The balance outstanding and unexercised at the end of the fiscal year was equivalent to 1.15 million shares. - FY2023-Q1AdvancedAnnual report
「The Stock Acquisition Rights issued under the Companies Act during the first quarter accounting period are as follows. Date of resolution 19 July 2022 (Series 13 Stock Acquisition Rights) Number of Stock Acquisition Rights (units) 370 Class, description and number of shares underlying the Stock Acquisition Rights (shares) Common shares: 3,700,000」
The company issued Series 13 Stock Acquisition Rights covering 370 units and 3,700,000 common shares. The initial exercise price was ¥173, and the exercise period was from 4 August 2022 to 3 August 2024. - FY2021AdvancedAnnual report
「The stock options outstanding during the fiscal year ended July 2021 are covered, and the number of stock options is stated on a converted share basis.」
Series 11 Stock Acquisition Rights equivalent to 107,500 shares vested, and 25,810 shares, including rights from earlier series, were exercised. The total balance outstanding and unexercised at the end of the fiscal year, including Series 11, was equivalent to 330,440 shares. - FY2021-Q3Increase in the balance of Stock Acquisition RightsAnnual report
「The main factors were increases of ¥204.208 million in retained earnings and ¥20.532 million in Stock Acquisition Rights.」
The company disclosed that Stock Acquisition Rights increased by ¥20.532 million, contributing to the increase in net assets. - FY2021-Q2AdvancedAnnual report
「Date of resolution 28 October 2020 (Series 11 Stock Acquisition Rights) Categories and number of eligible grantees Directors of the company, excluding Directors serving as Audit and Supervisory Committee Members: 5 Directors of the company serving as Audit and Supervisory Committee Members: 1 Number of Stock Acquisition Rights (units)* 1,075 (Note 1) Class, description and number of shares underlying the Stock Acquisition Rights (shares)* Common shares: 107,500」
The issuance of Series 11 Stock Acquisition Rights was approved on 28 October 2020, and 1,075 units, equivalent to 107,500 common shares, were granted to 5 directors excluding Directors serving as Audit and Supervisory Committee Members and 1 Director serving as an Audit and Supervisory Committee Member. The exercise period was from 20 November 2020 to 19 November 2050. - FY2020RestatedAnnual report
「25 October 2019 (Series 10 Stock Acquisition Rights) Number of Stock Acquisition Rights (units): 697; Class and number of shares underlying the Stock Acquisition Rights (shares): Common shares, 69,700; Exercise period for the Stock Acquisition Rights: From 21 November 2019 to 20 November 2049」
The issuance of 697 Series 10 Stock Acquisition Rights, equivalent to 69,700 shares, was confirmed for the full fiscal year. The same number remained outstanding and unexercised at the end of the fiscal year. - FY2020-Q2AdvancedAnnual report
「Number of Stock Acquisition Rights (units)* 697 (Note 1) Class, description and number of shares underlying the Stock Acquisition Rights (shares)* Common shares: 69,700 (Note 1) Exercise period for the Stock Acquisition Rights* From 21 November 2019 To 20 November 2049」
The company issued 697 Series 10 Stock Acquisition Rights covering 69,700 common shares, with an exercise period from 21 November 2019 to 20 November 2049. - FY2019-Q2AdvancedAnnual report
「Number of Stock Acquisition Rights (units)* 688 (Note 1) Class, description and number of shares underlying the Stock Acquisition Rights (shares)* Common shares: 68,800 (Note 1) Exercise period for the Stock Acquisition Rights* From 21 November 2018 To 20 November 2048」
The company issued Series 9 Stock Acquisition Rights covering 688 units and 68,800 common shares, with an exercise period from 21 November 2018 to 20 November 2048. - FY2018AdvancedAnnual report
「8th stock acquisition rights: Granted 47,300; vested 47,300; unexercised balance 47,300」
For the Series 8 Stock Acquisition Rights issued at the end of the previous fiscal year, the grant and vesting of rights equivalent to 47,300 shares were disclosed. As of the end of the fiscal year, none had been exercised. - FY2018-Q2First statedAnnual report
「Number of stock acquisition rights (units): 473 (Note 1) Number of shares underlying the stock acquisition rights (shares): 47,300 (Note 2) Exercise period: 21 November 2017 to 20 November 2047 (Note 3)」
During the second-quarter accounting period, the Company issued 473 stock acquisition rights, representing 47,300 underlying shares, with an exercise period from 21 November 2017 to 20 November 2047. The payment amount upon exercise is ¥1, the issue price is ¥213, and the amount transferred to stated capital is ¥107.